Evidence-based management of schizophrenia
- PMID: 15127672
- DOI: 10.12968/hosp.2004.65.4.12731
Evidence-based management of schizophrenia
Abstract
Antipsychotic medication is the foundation of care for patients who suffer from schizophrenia and other psychotic conditions. Newly diagnosed patients should be treated with atypical antipsychotics, of which the National Institute for Clinical Excellence guidelines recommend five. The quality of clinical evidence will ultimately establish the differences between available treatments.
Similar articles
-
What do large scale studies of medication in schizophrenia add to our management strategies?Psychiatr Danub. 2010 Jun;22(2):323-8. Psychiatr Danub. 2010. PMID: 20562774 Review.
-
[Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].Neuropsychopharmacol Hung. 2012 Sep;14(3):189-95. Neuropsychopharmacol Hung. 2012. PMID: 22987732 Review. Hungarian.
-
Generating evidence to inform policy and practice: the example of the second generation "atypical" antipsychotics.Schizophr Bull. 2003;29(1):105-14. doi: 10.1093/oxfordjournals.schbul.a006980. Schizophr Bull. 2003. PMID: 12908665
-
New generation vs. first generation antipsychotics debate: pragmatic clinical trials and practice-based evidence.Psychiatr Danub. 2009 Dec;21(4):446-52. Psychiatr Danub. 2009. PMID: 19935477
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
Cited by
-
Long term outcome of treating schizophrenia.BMJ. 2004 Nov 6;329(7474):1058-9. doi: 10.1136/bmj.329.7474.1058. BMJ. 2004. PMID: 15528595 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical